Épidémiologie de la maladie de Parkinson, données nationales / Epidemiology of Parkinson's disease, French national data, p.43 ,
Guide parcours de soins. Maladie de Parkinson, 2016. ,
Les Ruptures de soins dans la maladie de Parkinson CAP PARK Comprendre, Agir, Prévenir Résultats et analyses du questionnaire, Journée mondiale, 2015. ,
Idiopathic Parkinson's Disease: Staging an ?-Synucleinopathy with a Predictable Pathoanatomy, Landes Bioscience, 2013. ,
Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California, American Journal of Epidemiology. 15 avr, vol.169, issue.8, pp.919-945, 2009. ,
High risk of Parkinson's disease for people exposed to pesticides near workplace, UCLA Newsroom ,
Glucocerebrosidase and Parkinson disease: Recent advances, Mol Cell Neurosci. mai, vol.66, pp.37-42, 2015. ,
Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset, Mov Disord. avr, vol.21, issue.4, pp.534-543, 2006. ,
Maladie de Parkinson à début précoce, Orphanet. Mai, 2006. ,
MDS clinical diagnostic criteria for Parkinson's disease, Movement Disorders, vol.30, issue.12, pp.1591-601, 2015. ,
Etude physiopathologique de la douleur dans la maladie de Parkinson : approches pharmacologique, en neuroimagerie et évaluation des effets de la stimulation cérébrale profonde du noyau sous-thalamique ,
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review, J Neurol, vol.260, issue.11, pp.2701-2715, 2013. ,
International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease, Movement Disorder Society Evidence-Based Medicine Committee, 2018. ,
Exercise and Parkinson's: benefits for cognition and quality of life, Acta Neurol Scand. janv, vol.123, issue.1, pp.13-22, 2011. ,
Cognitivebehavioral therapy for depression in Parkinson's disease: a randomized, controlled trial, Am J Psychiatry, vol.168, issue.10, pp.1066-74, 2011. ,
Janine-Sophie) GL. L'annonce diagnostique dans la maladie chronique. L'annonce diagnostique dans la maladie chronique, 2010. ,
Étude descriptive de la population parkinsonienne de la région Hauts-de-France : analyse épidémiologique et consommation de soins, Revue Neurologique. 1 mars, vol.173, pp.133-137, 2017. ,
Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France, Mov Disord, vol.26, issue.12, pp.2226-2257, 2011. ,
Drug induced parkinsonism: a common cause of parkinsonism in older people, Postgrad Med J. juin, vol.85, pp.322-328, 1004. ,
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease, Mov Disord, vol.26, issue.3, pp.2-41, 2011. ,
Essential Tremor and Extra-Pyramidal Dyskinesias A, Chronic VIM Thalamic Stimulation in Parkinson's Disease ,
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease, New England Journal of Medicine, vol.339, issue.16, pp.1105-1116, 1998. ,
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?, Parkinsonism Relat Disord. avr, vol.20, issue.4, pp.376-81, 2014. ,
Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients, Neurosurgery, vol.61, pp.297-305, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00336994
Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon, J Neurol, vol.256, issue.10, pp.1736-1777, 2009. ,
Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study, Parkinsonism Relat Disord, vol.19, issue.1, pp.56-61, 2013. ,
Apomorphine: an underutilized therapy for Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, vol.15, 2000. ,
Étude OPTIPUMP : stimulation continue par injection d'apomorphine. Description des stratégies thérapeutiques et leur impact sur la qualité de vie à 6 mois et la tolérance ,
Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications, Parkinsonism & Related Disorders. 1 janv, vol.18, issue.1, pp.40-44, 2012. ,
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study, The Lancet Neurology. 1 févr, vol.13, issue.2, pp.141-150, 2014. ,
, Article 11 -Développement professionnel continu. Conseil National de l'Ordre des Médecins
La formation médicale continue des médecins généralistes en Rhône-Alpes: description et comparaison entre milieu urbain et rural par enquête quantitative auprès de 140 médecins généralistes, 2017. ,
, Mission des centres experts pour la prise en charge de la maladie de Parkinson
,
Coopération ville-hôpital : le point de vue des médecins généralistes, 2010. ,
, Code de la santé publique -Article R4127-56
, Institu Français d'Opinion Public. 23 mars, 2017.
Etude des relations entre les médecins généralistes de la région de Pau et le centre hospitalier de rattachement de Pau pour améliorer la prise en charge mutualisée des patients Thèse de médecine, 2014. ,
,